Form 4 for RGEN REPLIGEN CORP
Accepted 2025-12-17 00:00:00 ET · period of report 2025-12-16 · accession 0001193125-25-322821 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-17 | 2025-12-16 | RGEN | MUIR GLENN P | Dir | M - OptEx | $26.12 | +3,366 | 36.6K | +10% | +$87.9K |
| D | 2025-12-17 | 2025-12-16 | RGEN | MUIR GLENN P | Dir | M - OptEx | $0.00 | +3,366 | 3,366 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-16 | M | A | 3,366 | $26.12 | 36,622 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-12-16 | M | A | 3,366 | $0.00 | 3,366 | D | $26.12 · — to 2026-05-11 | 3,366 Common Stock | (F1) This option is fully vested and exercisable. |